MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells. Biochem. Pharmacol. 2015, 98, 215-123. [CrossRef] [PubMed]D. Yu, B. Green, W.H. Tolleson, Y. Jin, N. Mei, Y. Guo, et al., MicroRNA hsa-miR- 29a-3p modulates CYP2C19 in human liver cells, Biochem. Pharmacol....
MicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cellsDianke Yua, Bridgett Greena, William H. Tollesona, Yaqiong Jinb, Nan Meia, Yongli Guob,Helen Dengc, Igor Pogribnya, Baitang Ninga,*aNational Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR ...
Discover Oncology Research Hsa_circYARS interacts with miR‑29a‑3p to up‑regulate IREB2 and promote laryngeal squamous cell carcinoma progression Zizhao Guo1 · Yuxia Zhao2 · Naicai Guo3,5 · Meng Xu1,4 · Xiaolei Wang1 Received: 10 January 2024 / Accepted...
Jules-Roger Kuiaté aMauro Giacca eAlexis Ndjolo b jTuberculosisElvis Ndukong Ndzi,Céline Nguefeu Nkenfou,Linda Mouafo Mekue,etc.MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis[J].2019,114....
As a result of miR-29a-3p enhancement or circYARS silence, the proliferative, migratory, and invasion of cancer cells were suppressed and apoptosis was stimulated. Conclusion: circYARS is involved in the tumorigenicity and progression of LSCC through the miR-29a-3p/IREB2 axis, providing ...
Serum levels of hsa‐miR‐16‐5p, hsa‐miR‐29a‐3p, hsa‐miR‐150‐5p, hsa‐miR‐155‐5p and hsa‐miR‐223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC studychronic lymphocytic leukemiacirculating miRNAserumprospective study...
hsa‐miR‐155‐5p and hsa‐miR‐29a‐3p was associated with subsequent risk of CLL [ OR 1Ct‐unit increase (95%CI) = 1.42 (1.18–1.72), 1.64 (1.31–2.04) and 1.75 (1.31–2.34) for hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 29a‐3p , respectively] and the strongest...
目的hsa-miR-125a-3p和hsa-miR-125a-5p是人miR-125a的两种成熟体microRNA(miRNA),分别来自前体pre-miR-125a的3'端和5'端.因为在先前的研究中,我们发现hsa-miR-125a-3... 江黎黎,邱雪杉,王恩华 - 中华医学会病理学分会学术年会 被引量: 0发表: 0年 加载更多来源...
hsa‐miR‐155‐5p and hsa‐miR‐29a‐3p was associated with subsequent risk of CLL [ OR 1Ct‐unit increase (95%CI) = 1.42 (1.18–1.72), 1.64 (1.31–2.04) and 1.75 (1.31–2.34) for hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 29a‐3p , respectively] and the strongest...